October 1, 2010, Teaneck, NJ DFW Capital Partners announced today that it has completed the sale of its portfolio company, ALVP Holdings, which includes operating subsidiaries Alaven Pharmaceuticals and Alaven Consumer Healthcare, to Swedish specialty pharmaceutical company Meda AB. Meda acquired Alaven for an aggregate cash purchase price of $350 million, resulting in a realized… Read more »
DFW Capital Partners announced today that it has closed the recapitalization of Meta Pharmaceutical Services, a leading outsourced service provider to the pharmaceutical industry. DFW invested preferred equity, and raised senior and subordinated debt financing, to facilitate a liquidity event for Meta’s founders, while leaving the core operating team with a significant remaining equity stake.… Read more »
Garden State Dental Management (“GSDM”) announced today that it has closed the acquisition of American Dental Concepts (“ADC”). The add-on acquisition was funded in part by funds from DFW Capital Partners III L.P. The transaction adds twelve new offices to the GSDM platform nearly doubling the size of the Company. The ADC offices are located… Read more »
DFW Capital Partners announced today that it has held a final closing on DFW Capital Partners III, L.P., a partnership dedicated to making control investments in lower-middle market service companies. DFW III is capitalized with $54.1 million in commitments from institutional investors, as well as family offices and other high net worth individuals. As with… Read more »
DFW Capital Partners announced today that Brian Tilley has joined the firm as a General Partner. Brian will manage DFW’s Washington, DC office. Prior to joining DFW, Brian was the founder and Managing Member of Wenzi Capital Partners, LLC. Brian previously spent ten years at AmeriChoice Corporation and subsequently with United HealthGroup after United acquisition… Read more »
April 30, 2009, Teaneck, NJ. DFW Capital Partners announced today that it has led the recapitalization of SoftWriters, Inc., based on Allison Park, PA. The transaction facilitated a liquidity event for the company’s founder, and provided a significant continuing equity ownership position for SoftWriters’ key management and employees. DFW completed this investment, in part, with… Read more »
DFW Capital Partners announced today that it has led the acquisition of a controlling interest in Venio. DFW completed this investment, in part, with funds from its most recent private equity fund, DFW Capital Partners III L.P. Headquartered in New York City, Venio is a leading provider of asset recovery services, specializing in uniting heirs… Read more »
December 15, 2008, Teaneck, NJ. DFW Capital Partners announced today that its portfolio company, Alaven Pharmaceutical, has acquired the assets of DrNatura, a leading web-based direct-to-consumer marketer of colon and digestive health products. As part of the transaction, Alaven created a separate subsidiary, Alaven Consumer Health, to house DrNatura and Alaven’s other OTC Alaven products.… Read more »
DFW Capital Partners announced today that it has led the acquisition of a majority interest in The Copernicus Group IRB, from its founding owners. DFW recruited pharmaceutical industry veteran, Bruce Tomason, to become CEO of Copernicus and lead the business post-acquisition. DFW completed this investment, in part, with funds from its most recent private equity… Read more »
DFW Capital Partners announced today that it has completed the sale of its portfolio company, Andrews International, to Boston-based private equity firm Audax Group for an aggregate purchase price of $161 million. DFW realized a 30% IRR and a 2.6x ROI on its investment in Andrews. DFW originally invested in Andrews’ predecessor company in 2004,… Read more »